Assessing the early effects of OPN, we confirm that this protein impairs BBB function in vitro and demonstrate in an in vivo model of ischemic stroke that therapeutic neutralization using an anti-OPN antibody preserves the integrity of the BBB. Here, SPP1 is linked to ischemic stroke.